Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease

NCT02792413 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Modified study and new deposit in RECHMPL21\_0451

Conditions

Female With Osteoporosis and Chronic Kidney Disease

Interventions

DRUG: Denosumab
DRUG: NaCl (placebo)

Sponsor

University Hospital, Montpellier